GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viveve Medical Inc (OTCPK:VIVE) » Definitions » Cyclically Adjusted Price-to-FCF

Viveve Medical (Viveve Medical) Cyclically Adjusted Price-to-FCF : (As of May. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Viveve Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Viveve Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Viveve Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viveve Medical Cyclically Adjusted Price-to-FCF Chart

Viveve Medical Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Viveve Medical Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Viveve Medical's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Viveve Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Viveve Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Viveve Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Viveve Medical's Cyclically Adjusted Price-to-FCF falls into.



Viveve Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Viveve Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, Viveve Medical's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2022 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.332/125.2265*125.2265
=-0.332

Current CPI (Sep. 2022) = 125.2265.

Viveve Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201212 -85.857 96.871 -110.988
201303 -308.286 98.209 -393.095
201306 -101.714 98.518 -129.289
201309 -188.571 98.790 -239.033
201312 -3,837.500 98.326 -4,887.387
201403 -3,943.750 99.695 -4,953.754
201406 -3,400.000 100.560 -4,234.012
201409 -1,438.500 100.428 -1,793.710
201412 -969.500 99.070 -1,225.471
201503 -837.000 99.621 -1,052.132
201506 -849.500 100.684 -1,056.573
201509 -542.833 100.392 -677.120
201512 -552.286 99.792 -693.047
201603 -297.857 100.470 -371.250
201606 -544.125 101.688 -670.077
201609 -543.636 101.861 -668.339
201612 -538.636 101.863 -662.181
201703 -683.333 102.862 -831.903
201706 -501.632 103.349 -607.820
201709 -492.263 104.136 -591.963
201712 -456.526 104.011 -549.645
201803 -602.038 105.290 -716.036
201806 -270.452 106.317 -318.555
201809 -328.742 106.507 -386.522
201812 -305.667 105.998 -361.117
201903 -255.152 107.251 -297.917
201906 -179.022 108.070 -207.443
201909 -114.203 108.329 -132.016
201912 -7.928 108.420 -9.157
202003 -6.604 108.902 -7.594
202006 -3.230 108.767 -3.719
202009 -1.581 109.815 -1.803
202012 -1.233 109.897 -1.405
202103 -0.387 111.754 -0.434
202106 -0.355 114.631 -0.388
202109 -0.259 115.734 -0.280
202112 -0.332 117.630 -0.353
202203 -0.484 121.301 -0.500
202206 -0.435 125.017 -0.436
202209 -0.332 125.227 -0.332

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Viveve Medical  (OTCPK:VIVE) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Viveve Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Viveve Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Viveve Medical (Viveve Medical) Business Description

Traded in Other Exchanges
N/A
Address
345 Inverness Drive South, Building B, Suite 250, Englewood, CO, USA, 80112
Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
Executives
Presnell Sharon Collins director 6275 NANCY RIDGE DRIVE, SUITE 110, SAN DIEGO CA 92121
Goldman Sachs Group Inc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Goldman Sachs & Co. Llc 10 percent owner 200 WEST STREET, NEW YORK NY 10282
Wilmot B. Harkey 10 percent owner C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840
Daniel Mack 10 percent owner C/O NANTAHALA CAPITAL MANAGEMENT, LLC, 130 MAIN ST. 2ND FLOOR, NEW CANAAN CT 06840
Nantahala Capital Management, Llc 10 percent owner 130 MAIN ST., 2ND FLOOR, NEW CANAAN CT 06840
Karen L. Zaderej director AXOGEN INC., 13859 PROGRESS BLVD, SUITE 100, ALACHUA FL 32615
Steven L Basta director 1875 S GRANT STREET SUITE 110, SAN MATEO CA 94402
Scott Durbin officer: Chief Financial Officer PO BOX 376, ANN ARBOR MI 48106
James G. Atkinson officer: CBO & President 150 COMMERCIAL STREET, SUNNYVALE CA 94086
Patricia Scheller director, officer: CEO and Director 150 COMMERCIAL STREET, SUNNYVALE CA 94086
Jon M Plexico director, 10 percent owner 16430 N SCOTTSDALE RD 450, SCOTTSDALE AZ 85254
Stonepine Capital Management, Llc director, 10 percent owner 919 NW BOND STREET, SUITE 204, BEND OR 97703
Timothy P Lynch director, 10 percent owner 919 NW BOND STREET, SUITE 204, BEND OR 97703
Daniel Janney director, 10 percent owner PO BOX 7414, JACKSON WY 83002